Which Anti-VEGF Therapy (Ranibizumab, Bevacizumab, or Aflibercept) Demonstrates The Most Cost-Effective Outcomes For Treating Age-Related Macular Degeneration ? : A Systematic Review. the. Indonesian. j. gen. med. [Internet]. 2025 May 26 [cited 2026 Oct. 21];12(3):1-48. Available from: https://indonesianjournalmedicine.org/index.php/ijgm/article/view/142